VcMMAE (mc-vc-PAB-MMAE) is a drug-linker conjugate for ADC with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the lysosomally cleavable dipeptide, valine-citrulline. MC is a typical fragment of ADC linker.

We can provide high-quality VcMMAE and its derived impurities.Moreover, we provide the following technical development services:

Reliable and available kilogram-level supply;
kilogram-level GMP supply in commercial production stage;
Complete DMF registration;
CMC and regulatory affair service(IND, NDA) based on this product.


Product Specifications:purity≥99%, Total Impurities≤1.0%, KF≤1.0%